A double-blind controlled evaluation of Diproderm cream 0.05%, twice a day treatment in comparison with once a day treatment in eczema.

Abstract	A double-blind study, carried out at two centres, comparing once and twice a day application of betamethasone-17,21-dipropionate cream 0.05% (Diproderm), has shown that the efficacy in treating eczema is the same after 1 week.
Authors	L Gärtner, C Tarras-Wahlberg
Journal	The Journal of international medical research (J Int Med Res) Vol. 12 Issue 1 Pg. 59-61 ( 1984) ISSN: 0300-0605 [Print] England
PMID	6363158 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References	Anti-Inflammatory Agents Glucocorticoids Ointments betamethasone-17,21-dipropionate Betamethasone
Topics	Administration, Topical Adult Anti-Inflammatory Agents (therapeutic use) Betamethasone (administration & dosage, analogs & derivatives, therapeutic use) Clinical Trials as Topic Double-Blind Method Drug Administration Schedule Eczema (drug therapy) Female Glucocorticoids Humans Male Ointments

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!